ロード中...
Oral Salmonella msbB Mutant as a Carrier for a Salmonella-Based Vaccine for Prevention and Reversal of Type 1 Diabetes
A therapy that includes an oral vaccine for type 1 diabetes (T1D) using live attenuated Salmonella MvP728 (ΔhtrA/ΔpurD), cytokines (IL10 and TGFβ) and preproinsulin (PPI) antigen in combination with a sub-therapeutic dose of anti-CD3 mAb was developed by our team. The vaccine combination therapy red...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8181392/ https://ncbi.nlm.nih.gov/pubmed/34108968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.667897 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|